PINK1のアクティベーションメカニズム
Zhong Yan Gan1,2, Sylvie Callegari1,2, Simon A Cobbold1,2
1Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Nature
|December 21, 2021
まとめ
研究者はミトファジーとパーキンソン病の予防に不可欠なタンパク質キナーゼPINK1の活性化メカニズムを解明しました. この研究は,PINK1がミトコンドリアとどのように相互作用し,酸化によってその調節を明らかにしています.
科学分野:
- 生物化学
- 構造生物学
- 神経科学
背景:
- PINK1の変異は,ミトファギーを妨害することで,早期発症のパーキンソン病を引き起こす.
- PINK1はユビキチンとパーキンをリン酸化しますが,その活性化メカニズムは不明です.
研究 の 目的:
- タンパク質キナーゼPINK1の完全な活性化メカニズムを解明する.
- ミトコンドリアの外膜との相互作用を理解するために
- PINK1活性調節における酸化の役割を調査する.
主な方法:
- 非リン酸化PINK1のX線結晶学
- PINK1ジマーとリン酸化状態の冷凍電子顕微鏡 (冷凍EM)
- リン酸化研究と構造分析
主要な成果:
- 非リン酸化PINK1の構造を決定し,ミトコンドリアの方向性を示した.
- トランス・オートフォスフォリレーションと活性化中にPINK1の冷凍-EM構造を捕獲した.
- 反応性酸素種によるPINK1酸化の制御作用を特定した.
結論:
- 非酸化から活性化ユビキチンキナーゼへの完全なPINK1活性化経路を図示した.
- PINK1のミトコンドリアの関与に関する構造的な洞察を提供した.
- パーキンソン病の病原性におけるPINK1活性の主な調節因子としての酸化が明らかにされた.
関連する概念動画
01:22PI3K/mTOR/AKT Signaling Pathway
4.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.1K
01:07MAPK Signaling Cascades
6.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.4K
01:48ATP Synthase: Mechanism
15.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
15.5K
02:39Positive Regulator Molecules
5.8K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.8K
01:22Amplifying Signals via Enzymatic Cascade
13.1K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
13.1K
02:34Inhibition of Cdk Activity
5.0K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.0K